Overview Performance Dividends Fundamentals Peer Group Correlations Pair Trades Institutions Insider Forecasts Options

Performance of RGNX Regenxbio | -24.6% in 12m

Compare RGNX with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?

Compare Regenxbio with its related Sector/Index XBI

Compare Regenxbio with its related Sector/Index XBI

Performance Duell RGNX vs XBI

TimeFrame RGNX XBI
1 Day -0.42% 0.55%
1 Week 13.9% 4.13%
1 Month 24.5% 10.14%
3 Months -11.5% 21.77%
6 Months 12.7% 15.22%
12 Months -24.6% 20.63%
YTD -21.9% 12.67%
Rel. Perf. 1m 0.81
Rel. Perf. 3m -5.03
Rel. Perf. 6m -0.09
Rel. Perf. 12m -0.09

Is Regenxbio a good stock to buy?

No, based on ValueRay Fundamental Analyses, Regenxbio (NASDAQ:RGNX) is currently (July 2024) a stock to sell. It has a ValueRay Fundamental Rating of -69.11 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RGNX as of July 2024 is 13.11. This means that RGNX is currently overvalued and has a potential downside of -8.51% (Sold with Premium).

Is RGNX a buy, sell or hold?

  • Strong Buy: 6
  • Buy: 5
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
Regenxbio has received a consensus analysts rating of 4.55. Therefor, it is recommend to buy RGNX.
Values above 0%: RGNX is performing better - Values below 0%: RGNX is underperforming

Compare RGNX with Broad Market Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY 14.74% 24.70% 0.25% -45.17%
US NASDAQ 100 QQQ 16.49% 28.12% 3.10% -46.08%
US Dow Jones Industrial 30 DIA 13.16% 20.69% 5.20% -40.85%
German DAX 40 DBXD 12.52% 23.06% 4.56% -39.44%
UK FTSE 100 ISFU 12.72% 21.89% 1.11% -39.75%
Shanghai Shenzhen CSI 300 CSI 300 16.91% 24.80% 10.54% -8.99%
Hongkong Hang Seng HSI 15.33% 25.28% 16.66% -4.57%
Japan Nikkei 225 EXX7 15.42% 25.65% 11.12% -35.49%
India NIFTY 50 INDA 12.77% 21.60% -2.85% -51.52%
Brasil Bovespa EWZ 14.84% 23.11% 26.79% -12.18%

RGNX Regenxbio vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC 15.57% 27.13% 4.33% -47.51%
Consumer Discretionary XLY 16.68% 24.89% 5.83% -30.52%
Consumer Staples XLP 13.40% 22.89% 2.97% -31.26%
Energy XLE 14.10% 22.73% 1.47% -33.49%
Financial XLF 12.60% 18.67% -0.52% -49.57%
Health Care XLV 12.50% 21.86% 4.17% -38.18%
Industrial XLI 12.76% 20.71% 0.59% -40.81%
Materials XLB 12.56% 21.41% 1.04% -33.29%
Real Estate XLRE 13.37% 16.63% 5.04% -35.07%
Technology XLK 15.99% 28.90% 5.09% -46.79%
Utilities XLU 12.43% 21.04% -5.52% -34.33%
Aerospace & Defense XAR 10.27% 18.81% -2.42% -44.31%
Biotech XBI 9.78% 14.36% -2.56% -45.21%
Homebuilder XHB 9.62% 8.50% -11.15% -63.92%
Retail XRT 11.82% 21.87% 1.55% -40.07%

RGNX Regenxbio vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO 16.33% 27.85% 8.54% -28.60%
Natural Gas UNG 19.43% 50.72% 45.58% 27.92%
Gold GLD 14.41% 20.71% -5.32% -45.57%
Silver SLV 18.44% 27.65% -9.49% -36.88%
Copper CPER 16.45% 29.83% 5.54% -28.25%

Returns of RGNX vs. Yields & Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT 13.83% 24.35% 11.52% -21.17%
iShares High Yield Corp. Bond HYG 13.51% 22.61% 8.64% -34.74%
Does Regenxbio outperform its market, is RGNX a Sector Leader?
No, over the last 12 months Regenxbio (RGNX) made -24.58%, while its related Sector, the SPDR S&P Biotech (XBI) made 20.63%.
Over the last 3 months RGNX made -11.49%, while XBI made 21.77%.
Period RGNX XBI S&P 500
1 Month 24.50% 10.14% -0.20%
3 Months -11.49% 21.77% 7.46%
12 Months -24.58% 20.63% 20.59%